Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Methods. 2008 Jan;44(1):55-60.

Inhibition of microRNA with antisense oligonucleotides.

Author information

  • Isis Pharmaceuticals and Regulus Therapeutics, 1896 Rutherford Road, Carlsbad, CA 92008, USA. cesau@regulusrx.com

Abstract

Antisense inhibition of microRNA (miRNA) function has been an important tool for uncovering miRNA biology. Chemical modification of anti-miRNA oligonucleotides (AMOs) is necessary to improve affinity for target miRNA, stabilize the AMO to nuclease degradation, and to promote tissue uptake for in vivo delivery. Here I summarize the work done to evaluate the effectiveness of various chemically modified AMOs for use in cultured cells and rodent models, and outline important issues to consider when inhibiting miRNAs with antisense oligonucleotides.

PMID:
18158133
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk